Inhibiting HO-1 activity by the SnPP inhibitor reversed the anti-inflammatory effects of magnolol proving that magnolol inhibits P. gingivalis LPS-induced inflammation in macrophages activating the NRF2/HO-1 axis, suggesting a possible use of magnolol in treatment of periodontitis [101]. This evidence concerns the gene HMOX1 and periodontitis.